What does Precision BioSciences, Inc. do?
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides…
What is Precision BioSciences, Inc.'s P/E and P/B ratio?
Precision BioSciences, Inc. has a P/E ratio of -5.0 and a P/B ratio of 4.13.
What is Precision BioSciences, Inc.'s debt-to-equity ratio?
Precision BioSciences, Inc. has a debt-to-equity ratio of 0.62.
How much does Precision BioSciences, Inc. owe compared with what it owns?
Precision BioSciences, Inc. owes $0.64 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Precision BioSciences, Inc.'s Positivity rank?
Precision BioSciences, Inc. is ranked #5,204 of 6,774 companies globally and #2,789 of 4,000 in United States on PositoAI, with a Positivity Score of 18,106.
Does Precision BioSciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Precision BioSciences, Inc..
Where can I read the latest news about Precision BioSciences, Inc.?
Recent headlines about Precision BioSciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Precision BioSciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Precision BioSciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.